# Remifentanil Requirement for Acceptable Intubating Condition

> **NCT02655380** · PHASE4 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 51 (actual)

## Conditions studied

- Intubating Condition

## Interventions

- **DRUG:** Ketamine 1
- **DRUG:** Ketamine 2
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT02655380
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-19
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-04-16
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655380, "Remifentanil Requirement for Acceptable Intubating Condition". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT02655380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*